Michael Scolaro

Michael Scolaro

Oct 08, 2017

Group 6 Copy 177
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Impact of Soylent Consumption on Human Microbiome Composition

As students carry out their busy lifestyles, many are turning to inexpensive and convenient drink based...

Mapping Addiction

Addiction and drug dependence are preventable and treatable diseases. Understanding the neurophysiological...

Can immune cells prevent 3D printed blood vessels from falling apart?

Mass production of cells is limited by nutrient delivery. 3D printing of hydrogel has enabled the printing...

Backer Badge Funded